Abatacept Combined With a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease Prophylaxis: A Randomized Controlled Trial
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 28 Jan 2019
At a glance
- Drugs Abatacept (Primary) ; Ciclosporin; Methotrexate; Tacrolimus
- Indications Graft-versus-host disease; Transplant rejection
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 19 Mar 2018 Planned primary completion date changed from 1 Feb 2018 to 1 Jun 2018.
- 20 Dec 2017 Status changed from recruiting to active, no longer recruiting.